Literature DB >> 4590654

Adriamycin. A new anticancer drug with significant clinical activity.

R H Blum, S K Carter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4590654     DOI: 10.7326/0003-4819-80-2-249

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  173 in total

Review 1.  Cardiotoxicity of doxorubicin and other anthracycline derivatives.

Authors:  D Jain
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

2.  Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase.

Authors:  Michael J Mihm; Fushun Yu; David M Weinstein; Peter J Reiser; John Anthony Bauer
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

3.  [Cell cycle and carcinochemotherapy: reality or hope? (author's transl)].

Authors:  H Ehrhart
Journal:  Langenbecks Arch Chir       Date:  1975-11

4.  Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet-visible high-performance liquid chromatography.

Authors:  David L Chin; Bert L Lum; Branimir I Sikic
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-11-05       Impact factor: 3.205

Review 5.  The role of antitumor antibiotics in current oncologic practice.

Authors:  H L Davis; D D von Hoff; J E Henney; M Rozencweig
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 6.  Toxicological and pathophysiological roles of reactive oxygen and nitrogen species.

Authors:  Ruth A Roberts; Robert A Smith; Stephen Safe; Csaba Szabo; Ronald B Tjalkens; Fredika M Robertson
Journal:  Toxicology       Date:  2010-07-17       Impact factor: 4.221

7.  Response of urinary malondialdehyde to factors that stimulate lipid peroxidation in vivo.

Authors:  S N Dhanakoti; H H Draper
Journal:  Lipids       Date:  1987-09       Impact factor: 1.880

8.  Fabrication of elastin-like polypeptide nanoparticles for drug delivery by electrospraying.

Authors:  Yiquan Wu; J Andrew MacKay; Jonathan R McDaniel; Ashutosh Chilkoti; Robert L Clark
Journal:  Biomacromolecules       Date:  2009-01-12       Impact factor: 6.988

9.  Uptake and metabolism of daunorubicin by human myelocytic cells.

Authors:  G Vasanthakumar; N K Ahmed
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 10.  Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity.

Authors:  Brian C Jensen; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2013-01       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.